• No results found

University of Groningen Development and applications of novel strategies for the enhanced mass spectrometric quantification of biogenic amines van Faassen, Martijn

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Development and applications of novel strategies for the enhanced mass spectrometric quantification of biogenic amines van Faassen, Martijn"

Copied!
4
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Development and applications of novel strategies for the enhanced mass spectrometric

quantification of biogenic amines

van Faassen, Martijn

DOI:

10.33612/diss.134196271

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van Faassen, M. (2020). Development and applications of novel strategies for the enhanced mass

spectrometric quantification of biogenic amines. University of Groningen.

https://doi.org/10.33612/diss.134196271

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Development and applications of novel strategies

for the enhanced mass spectrometric quantification of biogenic amines

(3)

COLOFON

Development and applications of novel strategies

for the enhanced mass spectrometric quantification of biogenic amines

Martijn van Faassen

Copyright © 2020 Martijn van Faassen

All rights reserved. No part of this thesis may be reproduced, stored or transmitted in any way or by any means without the prior permission of the author, or when applicable, of the publishers of the scientific papers. The author gratefully acknowledges the financial support for printing this thesis by:

Spark Holland B.V. Waters Corporation

Cover design by Harma Makken

Layout and design by Harma Makken, persoonlijkproefschrift.nl Printing: Ridderprint | www.ridderprint.nl

Development and applications of

novel strategies for the enhanced

mass spectrometric quantification

of biogenic amines

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 14 oktober 2020 om 16.15 uur

door

Hermannus Johannes Roelof van Faassen

geboren op 11 april 1980

(4)

TABLE OF CONTENTS

Chapter 1 General introduction and outline of the thesis 6 Chapter 2 Quantitative profiling of platelet-rich plasma indole markers in patients with

neuroendocrine tumors by direct-matrix derivatization combined with LC-MS/MS Clin. Chem. 2019; 65(11): 1388-1396

16

Chapter 3 In matrix derivatization combined with LC-MS/MS results in ultrasensitive quantification of plasma catecholamines and metanephrines

Anal. Chem. 2020; 92(13): 9072-9078

42

Chapter 4A Relationship between plasma and salivary melatonin and cortisol investigated by LC-MS/MS

Clin Chem Lab Med. 2017; 55(9): 1340-1348

74

Chapter 4B Melatonin is not stored in platelets Clin Chim Acta. 2019; 498: 17-20

94

Chapter 5 Mass spectrometric quantification of urinary 6-sulfatoxymelatonin: Age-dependent excretion and biological variation

Clin Chem Lab Med. 2020 Jul 16. doi: 10.1515/cclm-2020-0455

104

Chapter 6 Use of selective serotonin reuptake inhibitors is associated with very low plasma free serotonin concentrations in humans

Ann Clin Biochem. 2020; 57(1): 59-63

124

Chapter 7 Platelet serotonin concentrations are lower in renal cell carcinoma and pancreatic neuroendocrine tumor patients compared to healthy individuals: a role for indoleamine 2,3-dioxygenase

134

Chapter 8 Effective niacin (vitamin B3) suppletion in patients with serotonin producing neuroendocrine tumors

Neuroendocrinology. 2016; 103(5): 489-494

154

Chapter 9 Summary and future perspectives 168

Chapter 10 Nederlandse samenvatting (Dutch summary) 182

Dankwoord (Acknowledgments) 192

List of publications 200

Promotores

Prof. dr. I.P. Kema

Prof. dr. R.P.H. Bischoff

Prof. dr. E.G.E. de Vries

Beoordelingscommissie

Prof. dr. F. Kuipers

Prof. dr. S.J.L. Bakker

Prof. dr. R. de Jonge

Referenties

GERELATEERDE DOCUMENTEN

Verder wordt bij het begrotingscriterium voor de Europese bankenbelasting gekeken naar de verkrijging van een belangrijke bijdrage van de financiële sector, waarbij specifiek de

To explore whether serotonin plays a role in cancer patients, we determined platelet serotonin concentrations by LC-MS/MS in patients with metastatic renal cell carcinomas

Boxplots showing the distribution of concentrations of PRP tryptophan (A), natural logarithmic transformed PRP 5-HTP (B), platelet serotonin (C), and natural logarithmic

MS settings, derivatization optimization experiment, recovery, proficiency study RCPA, chemical structures and pathway, scheme online SPE procedure, figure effect incubation time on

we investigated the correlations between total plasma, free plasma and salivary cortisol and melatonin levels by a fully validated LC-MS/MS method and show for the first time

analyzed with enzyme-linked immunosorbent assay (ELISA) on the x-axis versus analyzed with isotope dilution liquid chromatography combined with mass spectrometry (LC-MS/MS) on

Data on plasma free serotonin concentrations in SSRI users is lacking, while plasma free serotonin is available for receptor binding and plays a role in several pathophysiological

To evaluate if serotonin can also play a role in cancer patients, we compared platelet serotonin concentrations in patients with highly vascular metastatic renal cell carcinomas